ACAD — ACADIA Pharmaceuticals Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in ACADIA Pharmaceuticals Inc (ACAD), worth $32.69M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $32.45M | 0.04% | -25.6% |
| IMC | $226.66K | 0.00% | NEW |
| Persistent | $18.09K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.